Functional Outcome After ORIF or Arthroplasty for Femoral Neck Fracture
Launched by UPPSALA UNIVERSITY · Nov 21, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the best surgical treatment for older adults with a specific type of hip fracture called an undisplaced femoral neck fracture. The study compares two common surgical options: internal fixation (using screws to hold the bone together) and hip arthroplasty (replacing the damaged joint with an artificial one). Researchers want to see how these procedures affect physical function and pain levels for patients at 4 and 12 months after surgery.
To be eligible for this study, patients must be older adults who have recently suffered an undisplaced femoral neck fracture and are able to give informed consent. They should be treated at a participating hospital and be suitable for either type of surgery. If chosen to participate, individuals will receive follow-up calls or letters to answer questions about their recovery and daily activities. This study will help doctors understand which treatment may offer better outcomes for older patients facing this type of hip fracture.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Undisplaced (Garden I-II) femoral neck fracture (within 72h)
- • Treated at participating unit
- • Informed consent
- • Amenable for both treatment options
- • Included in the Hipsther trial
- Exclusion Criteria:
- • No informed consent
- • Pathological or stress fracture
- • Peri-implant fracture
- • Previous inclusion of a contralateral Garden 1 or 2 femoral neck fracture
About Uppsala University
Uppsala University, a prestigious institution located in Sweden, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of health sciences to conduct innovative studies aimed at improving patient outcomes and understanding complex diseases. With a strong emphasis on ethical standards and rigorous scientific methodologies, Uppsala University collaborates with a network of researchers, healthcare professionals, and industry partners to facilitate groundbreaking clinical trials that contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Uppsala, , Sweden
Patients applied
Trial Officials
Olof Wolf, MD, PhD
Principal Investigator
Uppsala University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported